Skip to main navigation Skip to search Skip to main content

ADDRESS+: An open-label, multicenter, follow-up trial of ARGX-113-1905 to evaluate the safety, tolerability, and efficacy of efgartigimod PH20 SC in patient with pemphigus

Project: Research

Project Details

StatusFinished
Effective start/end date01/29/21 → 10/31/25

Funding

  • PPD Investigator Services LLC: $69,090.07